Personalized Genetic Diagnosis of Congenital Heart Defects in Newborns

Olga María Diz1,2, Rocio Toro3, Sergi Cesar4

  • 1UGC Laboratorios, Hospital Universitario Puerta del Mar, 11009 Cadiz, Spain.

Insights

Genetic variants are key to congenital heart disease (CHD), a major cause of neonatal mortality. Early diagnosis using advanced genetic technologies enables personalized treatment approaches for these common heart malformations.

Area of Science:

  • Cardiology
  • Medical Genetics
  • Developmental Biology

Background:

  • Congenital heart disease (CHD) encompasses structural heart and great vessel malformations during embryonic development.
  • CHD is the most common severe congenital malformation and a leading cause of neonatal mortality.
  • Severity varies based on anatomical defects; causes are multifactorial with significant genetic contributions.

Purpose of the Study:

  • To provide an updated review of the genetic underpinnings of frequent CHDs and associated syndromes.
  • To explore the translation of genetic data into clinical practice for personalized CHD management.

Main Methods:

  • Review of current literature on genetic bases of congenital heart defects.
  • Analysis of high-throughput genetic technologies for variant identification (aneuploidies, deletions/duplications, single nucleotide variants).

Main Results:

  • Genetic variants play a crucial role in the etiology of congenital heart disease.
  • High-throughput technologies facilitate the identification of various pathogenic genetic alterations.
  • Early diagnosis is essential for personalized management strategies.

Conclusions:

  • Genetic factors are fundamental to understanding congenital heart disease.
  • Advanced genetic diagnostics are vital for early and precise diagnosis.
  • Translating genetic findings into clinical practice is key for personalized patient care.